CD40LG and B-cell chronic lymphocytic leukemia: Interestingly, the combination of the two agents was significantly more toxic than each agent alone against anti-IgM-stimulated CLL cells (Fig. 8a), suggesting that a combination of these drugs could be effective in overcoming resistance induced by BCR signals.